Newtyn Management as of March 31, 2024
Portfolio Holdings for Newtyn Management
Newtyn Management holds 40 positions in its portfolio as reported in the March 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Iac Com New (IAC) | 15.1 | $76M | 1.4M | 53.34 | |
| PAR Technology Corporation (PAR) | 11.3 | $57M | 1.2M | 45.36 | |
| Cannae Holdings (CNNE) | 9.4 | $47M | 2.1M | 22.24 | |
| Bristow Group (VTOL) | 5.8 | $29M | 1.1M | 27.20 | |
| Merrimack Pharmaceuticals In Com New | 5.5 | $28M | 1.9M | 14.77 | |
| Apartment Invt & Mgmt Cl A (AIV) | 4.9 | $25M | 3.0M | 8.19 | |
| Cogent Communications Hldgs Com New (CCOI) | 4.9 | $25M | 375k | 65.33 | |
| Spectrum Brands Holding (SPB) | 4.4 | $22M | 250k | 89.01 | |
| City Office Reit (CIO) | 4.0 | $20M | 3.8M | 5.21 | |
| Orthofix Medical (OFIX) | 3.7 | $19M | 1.3M | 14.52 | |
| Mitek Sys Com New (MITK) | 3.3 | $16M | 1.2M | 14.10 | |
| Theravance Biopharma (TBPH) | 2.9 | $15M | 1.6M | 8.97 | |
| Mbia (MBI) | 2.5 | $13M | 1.9M | 6.76 | |
| Clearfield (CLFD) | 2.5 | $12M | 400k | 30.84 | |
| Galapagos Nv Spon Adr (GLPG) | 2.3 | $12M | 366k | 32.20 | |
| Peregrine Pharmaceuticals (CDMO) | 2.0 | $10M | 1.5M | 6.70 | |
| Ni Hldgs (NODK) | 1.8 | $9.2M | 605k | 15.15 | |
| Bv Finl Com New (BVFL) | 1.8 | $9.0M | 871k | 10.33 | |
| Star Hldgs Shs Ben Int (STHO) | 1.2 | $6.2M | 478k | 12.92 | |
| Forum Energy Technologies In Note 9.000% 8/0 (Principal) | 1.1 | $5.5M | 5.5M | 1.00 | |
| Fidelity Wise Origin Bitcoin SHS (FBTC) | 1.1 | $5.4M | 87k | 62.06 | |
| Kodiak Sciences (KOD) | 1.0 | $5.3M | 1.0M | 5.26 | |
| Algoma Stl Group (ASTL) | 1.0 | $5.0M | 591k | 8.49 | |
| PG&E Corporation (PCG) | 0.9 | $4.5M | 269k | 16.76 | |
| Forum Energy Technologies In (FET) | 0.8 | $3.9M | 194k | 19.98 | |
| Wave Life Sciences SHS (WVE) | 0.6 | $3.1M | 500k | 6.17 | |
| 89bio (ETNB) | 0.6 | $2.9M | 250k | 11.64 | |
| Mural Oncology Pub Ord Shs (MURA) | 0.5 | $2.4M | 500k | 4.89 | |
| Bolt Biotherapeutics | 0.5 | $2.4M | 1.7M | 1.40 | |
| Adaptive Biotechnologies Cor (ADPT) | 0.4 | $2.0M | 624k | 3.21 | |
| Phathom Pharmaceuticals (PHAT) | 0.3 | $1.8M | 165k | 10.62 | |
| Olema Pharmaceuticals (OLMA) | 0.3 | $1.7M | 150k | 11.32 | |
| Atea Pharmaceuticals (AVIR) | 0.3 | $1.6M | 400k | 4.04 | |
| Avrobio Ord (AVRO) | 0.3 | $1.4M | 1.1M | 1.28 | |
| Vanda Pharmaceuticals (VNDA) | 0.3 | $1.3M | 311k | 4.11 | |
| Aligos Therapeutics | 0.2 | $1.2M | 1.2M | 0.98 | |
| Sensei Biotherapeutics | 0.2 | $977k | 930k | 1.05 | |
| Adverum Biotechnologies Com New (ADVM) | 0.1 | $653k | 46k | 14.14 | |
| Black Diamond Therapeutics (BDTX) | 0.1 | $634k | 125k | 5.07 | |
| Leafly Holdings *w Exp 02/04/202 (LFLYW) | 0.0 | $19k | 635k | 0.03 |
